ANNA MUNOZ: Open Payments
NPI 1730632084 · MERCEDES, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$860 in 9 payments from 9 companies in 2025. Trend: 2023 $1,055 · 2024 $842 · 2025 $860
Food & beverage: $860
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 1 | $164 |
| BioMarin Pharmaceutical Inc. | 1 | $134 |
| KYOWA KIRIN, INC. | 1 | $125 |
| Insulet Corporation | 1 | $104 |
| Sage Therapeutics, LLC | 1 | $100 |
| AstraZeneca Pharmaceuticals LP | 1 | $93 |
| Dexcom, Inc. | 1 | $76 |
| Lilly USA, LLC | 1 | $35 |
| GlaxoSmithKline, LLC. | 1 | $30 |
Products named: FREESTYLE LIBRE 3, VOXZOGO 1.2mg, OMNIPOD, LOKELMA, Dexcom G6 Transmitter, JARDIANCE, AREXVY.
Industry payments across TX — which companies pay providers there.
